Rayonier Advanced Materials (RYAM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Mar, 2026Executive summary
Annual meeting scheduled for May 13, 2026, at the corporate headquarters in Jacksonville, FL.
Shareholders can vote online, by phone, email, or in person, with deadlines for voting set for May 10 and May 12, 2026, depending on shareholding method.
Voting matters and shareholder proposals
Election of three directors: Charles R. Eggert, David C. Mariano, and Scott M. Sutton, all recommended by the board.
Proposal to amend the Certificate of Incorporation to declassify the board of directors.
Proposal to eliminate supermajority voting provisions from the Certificate of Incorporation.
Advisory vote on executive compensation (say-on-pay) included.
Approval sought for a French Sub-Plan under the 2023 Incentive Stock Plan.
Board of directors and corporate governance
Board recommends all director nominees and supports declassification and removal of supermajority voting.
Latest events from Rayonier Advanced Materials
- Board refresh, executive pay alignment, and governance reforms headline this year's proxy.RYAM
Proxy filing30 Mar 2026 - Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing20 Mar 2026 - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium20 Mar 2026 - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 20254 Mar 2026 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference3 Feb 2026 - Transformation to specialty cellulose, innovation, and sustainability drive growth and profitability.RYAM
Fireside Chat3 Feb 2026 - Shifting to specialty cellulose and biomaterials, with debt reduction and margin expansion in focus.RYAM
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 net sales and earnings surged, with 2024 guidance raised and cash flow outlook improved.RYAM
Q2 20242 Feb 2026 - Shifting to specialty cellulose and biomaterials, with asset sales and debt reduction underway.RYAM
Stifel 2024 Cross Sector Insight Conference1 Feb 2026